Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
Novartis Pharmaceuticals Corporation |
Mylan Pharmaceuticals Inc., Mylan Inc., Mylan Laboratories Limited and Viatris Inc. |
1:2021cv00146 |
December 20, 2021 |
US District Court for the Northern District of West Virginia |
Irene M Keeley |
Thomas S Kleeh |
Patent - Abbreviated New Drug Applications (ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on February 17, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 8 NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc. (Copland, Gordon) |
![]() |
Filing 6 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (dk) |
Filing 5 REPORT TO USPTO Other Document filed by Novartis Pharmaceuticals Corporation. (Companion, James) |
Filing 4 PLAINTIFF'S SUPPLEMENTAL ANDA Other Document filed by Novartis Pharmaceuticals Corporation. (Companion, James) |
Filing 3 PLAINTIFF'S RULE 7.1 DISCLOSURE STATEMENT Other Document filed by Novartis Pharmaceuticals Corporation. (Companion, James) |
Filing 2 VERIFICATION OF ATTORNEY ADMISSION re #1 Complaint to Nicholas Kallas, Christina Schwarz, Christopher Loh, and Jared Stringham. (dk) |
Filing 1 COMPLAINT against All Defendants, filed by Novartis Pharmaceuticals Corporation. Filing Fee $402.00. Receipt No. AWVNDC-3393348. (Attachments: #1 Exhibit A - U.S. Patent, #2 Civil Cover Sheet) (dk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.